Chris Heberlig Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Chris Heberlig.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Chris Heberlig. Chris Heberlig is Vice President, Finance in SYNAGEVA BIOPHARMA CORP ($GEVA).
Latest Insider Trading Transactions of Chris Heberlig
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 21 2012 | GEVA | SYNAGEVA BIOPHARMA ... | Heberlig Chris | Vice President, Fin ... | Option Exercise | M | 0.95 | 4,000 | 3,800 | 1,877 | |
| Dec 21 2012 | GEVA | SYNAGEVA BIOPHARMA ... | Heberlig Chris | Vice President, Fin ... | Sell | S | 46.07 | 1,605 | 73,942 | 0 | 1.6 K to 0 (-100.00 %) |
| Dec 21 2012 | GEVA | SYNAGEVA BIOPHARMA ... | Heberlig Chris | Vice President, Fin ... | Sell | S | 45.83 | 2,395 | 109,763 | 1,605 | 4 K to 1.6 K (-59.87 %) |
| Dec 21 2012 | GEVA | SYNAGEVA BIOPHARMA ... | Heberlig Chris | Vice President, Fin ... | Buy | M | 0.95 | 4,000 | 3,800 | 4,000 | 0 to 4 K |
| Oct 19 2012 | GEVA | SYNAGEVA BIOPHARMA ... | Heberlig Chris | Vice President, Fin ... | Option Exercise | M | 0.95 | 2,000 | 1,900 | 820 | |
| Oct 19 2012 | GEVA | SYNAGEVA BIOPHARMA ... | Heberlig Chris | Vice President, Fin ... | Option Exercise | M | 1.70 | 2,000 | 3,400 | 4,188 | |
| Oct 19 2012 | GEVA | SYNAGEVA BIOPHARMA ... | Heberlig Chris | Vice President, Fin ... | Sell | S | 49.67 | 2,000 | 99,340 | 0 | 2 K to 0 (-100.00 %) |
| Oct 19 2012 | GEVA | SYNAGEVA BIOPHARMA ... | Heberlig Chris | Vice President, Fin ... | Sell | S | 49.64 | 2,000 | 99,280 | 2,000 | 4 K to 2 K (-50.00 %) |
| Oct 19 2012 | GEVA | SYNAGEVA BIOPHARMA ... | Heberlig Chris | Vice President, Fin ... | Buy | M | 0.95 | 2,000 | 1,900 | 4,000 | 2 K to 4 K (+100.00 %) |
| Oct 19 2012 | GEVA | SYNAGEVA BIOPHARMA ... | Heberlig Chris | Vice President, Fin ... | Buy | M | 1.70 | 2,000 | 3,400 | 2,000 | 0 to 2 K |
| Sep 06 2012 | GEVA | SYNAGEVA BIOPHARMA ... | Heberlig Chris | Vice President, Fin ... | Option Exercise | M | 0.95 | 1,000 | 950 | 5,877 | |
| Sep 06 2012 | GEVA | SYNAGEVA BIOPHARMA ... | Heberlig Chris | Vice President, Fin ... | Sell | S | 49.52 | 300 | 14,856 | 0 | 300 to 0 (-100.00 %) |
| Sep 06 2012 | GEVA | SYNAGEVA BIOPHARMA ... | Heberlig Chris | Vice President, Fin ... | Sell | S | 48.92 | 700 | 34,244 | 300 | 1,000 to 300 (-70.00 %) |
| Sep 06 2012 | GEVA | SYNAGEVA BIOPHARMA ... | Heberlig Chris | Vice President, Fin ... | Buy | M | 0.95 | 1,000 | 950 | 1,000 | 0 to 1,000 |
| Jun 29 2012 | GEVA | SYNAGEVA BIOPHARMA ... | Heberlig Chris | Vice President, Fin ... | Option Exercise | A | 40.74 | 15,000 | 611,100 | 15,000 | |
| Jun 05 2012 | GEVA | SYNAGEVA BIOPHARMA ... | Heberlig Chris | Vice President, Fin ... | Option Exercise | M | 0.95 | 1,000 | 950 | 6,877 | |
| Jun 05 2012 | GEVA | SYNAGEVA BIOPHARMA ... | Heberlig Chris | Vice President, Fin ... | Sell | S | 36.44 | 200 | 7,287 | 0 | 200 to 0 (-100.00 %) |
| Jun 05 2012 | GEVA | SYNAGEVA BIOPHARMA ... | Heberlig Chris | Vice President, Fin ... | Sell | S | 35.56 | 800 | 28,446 | 200 | 1,000 to 200 (-80.00 %) |
| Jun 05 2012 | GEVA | SYNAGEVA BIOPHARMA ... | Heberlig Chris | Vice President, Fin ... | Buy | M | 0.95 | 1,000 | 950 | 1,000 | 0 to 1,000 |
Page: 1